Bioqube Ventures is a specialist life sciences investment firm based in Europe with a global reach. As an early-stage life science fund, we are dedicated to investing in exciting scientific breakthroughs in vibrant European ecosystems, with the aim of accelerating the development of breakthrough therapies for patients. At Bioqube Ventures, we source, finance, and develop innovative therapeutic assets and technologies.

Our expert team, consisting of fund managers, sector experts, and serial entrepreneurs, brings a hands-on approach to our investments. With our venture creation experience, we translate and de-risk scientific innovations, maximizing value for our investors. We are proud to have launched the Bioqube Factory Fund I in 2020, a life sciences venture capital fund specifically focused on advancing promising science in Europe.

Our unique dual investment model includes traditional investment rounds as well as special attention to Create projects that require additional experiments before creating new ventures. Through our in-house factory model, we are able to transform exciting science into trailblazing companies. Bioqube Ventures is supported by InnovFin Equity with the financial backing of the European Union under Horizon 2020, the Framework Programme for Research and Innovation